Waters (WAT) Stock

MILFORD, Mass., Nov. 20, 2024 /PRNewswire/ -- Waters Corporation (NYSE:WAT) has announced the appointment of Dr. Udit Batra.

Carson Block, the founder and Chief Investment Officer of Muddy Waters Research, appears on CNBC's 'The Exchange' to explain why his company is betting against e.l.f. Beauty. He shares his concerns that the company might be misrepresenting some of its information, among other topics.

A new 45,000 square foot facility has been opened at Longbridge Business Park, which focuses on science and technology, to accommodate engineering and skilled manufacturing workers. Waters has expanded its manufacturing space three times larger and enhanced its precision machining and metrology capabilities to prepare for future growth.

PITTSBURGH--(BUSINESS WIRE)--Confluence Technologies, Inc. (“Confluence”), a worldwide provider of technology solutions for regulatory, analytics, and investor communications in the investment management sector, is excited to share that its Revolution solution for multi-asset performance, attribution, and risk analytics has been recognized as the Best Buy-side Risk Management Initiative in the Last 12 Months by Waters Technology's Buy-side Technology Awards. This achievement marks the fourth time Confluence has received this honor.

WAT's results for the third quarter of 2024 indicate growth in the pharmaceutical and industrial sectors. However, a decline in sales in China presents some challenges.

Waters Corp. (WAT) saw its shares jump by almost 20% on Friday, making it the best performer in the S&P 500 for the day. This increase followed the company's announcement of third-quarter sales and earnings that exceeded what analysts had expected.

After two days of poor trading, major U.S. stock indexes ended the week positively, rising on Friday. Investors were encouraged by strong earnings reports from Amazon, a giant in e-commerce and cloud computing.

Waters Corp increased its yearly profit prediction after surpassing Wall Street's expectations for third-quarter earnings and revenue on Friday. This improvement was due to higher demand for its products and services used in drug development and research.

Waters Corporation reported sales of $740 million for the third quarter of 2024, surpassing expectations with a 4% increase in both reported and constant currency. All regions and end markets, particularly Pharma & Industrial, showed growth, while recurring revenue rose by high single digits in constant currency. The company also raised its full-year sales and earnings per share guidance, anticipating 5% to 7% growth in constant currency for the fourth quarter.